Skip to main content

Moreno Lab


Study of risk factors for Alzheimer’s disease

Type 2 diabetes

Study of the molecular mechanisms of protein coaggregation between pancreatic amylin and brain beta amyloid and tau.


Evaluation of the effect of late-life depression as a risk for Alzheimer’s disease.

Traumatic brain injury

Analysis of the mechanisms by which brain concussions can induce the onset of Alzheimer’s disease.

Preclinical analysis of therapies for neurodegenerative diseases

Stem cell therapy

Evaluation of the efficiency of neural precursors for the treatment of Alzheimer’s and Parkinson’s disease.


Study of photoactive compounds to treat Alzheimer’s disease.

Evaluation of blood components

Evaluation of blood components as a potential treatment for protein
misfolding disorders.